Insider Transactions in Q3 2022 at Sera Prognostics, Inc. (SERA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2022
|
John J. Boniface Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
844
+1.75%
|
$0
$0.73 P/Share
|
|
Jul 27
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,000
-2.1%
|
$2,000
$2.22 P/Share
|
|
Jul 27
2022
|
John J. Boniface Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+2.06%
|
$0
$0.73 P/Share
|
|
Jul 26
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-5.53%
|
$5,450
$2.15 P/Share
|
|
Jul 19
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-5.24%
|
$2,725
$1.86 P/Share
|
|
Jul 18
2022
|
Blue Ox Healthcare Partners, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,538,485
-93.39%
|
-
|
|
Jul 12
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-4.98%
|
$2,725
$1.84 P/Share
|
|
Jul 05
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-4.75%
|
$2,725
$1.63 P/Share
|